Pharmacopoeia
Contents
• Drug compendia
• Pharmacopoeia
• Different edition of Indian Pharmacopoeia
• Indian Pharmacopoeia Commission
• Contents of pharmacopoeia
• Contents of monograph of a compound: API, Plant origin,
Dosage forms, Vaccines and, Immuno sera
Learning
Objectives
At the end of this
lecture, the student will be able to:
• Define the drug compendia and classify it
• Define pharmacopoeia
• Classify pharmacopoeia
• List different edition of Indian Pharmacopoeia
• Recall about Indian Pharmacopoeia Commission
• Describe the various contents of pharmacopoeia
• Describe the various contents of monograph of a
compound/API plant origin, dosage forms, vaccines and immuno sera
Drug
Compendia
Pharmacopoeias and
Formularies:
-Standards for drugs and other related substances
Collectively these books are known as Drug Compendia
Classification:
The drug compendia are classified as:
• Official compendia
• Non-official compendia
Official compendia:
include
a) Indian Pharmacopoeia
b) British Pharmacopoeia
c) British Pharmaceutical Codex
d) United State Pharmacopoeia
e) National Formulary
f) Pharmacopoeia of other countries
2) Non-official
compendia: Include
a) Merck Index
b) Extra Pharmacopoeia (Martindale)
c) The United States Dispensary
INDIAN
PHARMACOPOEIA
Definition
• Pharmacopoeia:
The ancient Greek, φαρμακοποιΐα (pharmakopoiia),
• From φαρμακο- (pharmako-) ″drug″, ποι- (poi-) ″make″ and
-ια (-ia).
• These three elements together can be rendered as ″drug
making″ or ″to make a drug″.
• In its modern technical sense:
• It is a book containing directions for the identification
of compound medicines and
• published by the authority of a government or a medical or
pharmaceutical society
History of
Indian Pharmacopoeia
• In 1833,a committee of the East Indian Company’s
Dispensary recommended the Publication of Pharmacopoeia
• In 1844 Bengal Pharmacopoeia and General Conspectus of
Medicinal Plants was published, which mainly listed most of the commonly used
indigenous remedies
• In 1868 First official Pharmacopeia of India appeared
which was edited by Edward John Waring
• In pre independence days, British Pharmacopeia was used in
India
• The colonial addendum of BP 1898 was published in 1900,
appeared as Government of India edition in 1901
• In 1946 “The Indian Pharmacopeial list” under chairmanship
of Sir R. N. Chopra along with other nine members was released
• In 1948 Government of India appointed an Indian
Pharmacopeia committee for preparing “Pharmacopeia of India”
• Indian Pharmacopeia committee under chairmanship of Dr. B.
N. Ghosh Published first edition of IP in 1955
First
Indian Pharmacopoeia
The actual process of publishing the first Pharmacopoeia
started in the year 1944 under the chairmanship of Col. R. N. Chopra (Father of
Pharmacology)
Contributions:
• Indian Pharmacopoeial List -1946 Published as supplement
to British Pharmacopoeia
• The Indian Pharmacopoeia first edition- 1955
• The Pharmacy Act 1948
Indian Pharmacopoeia edition
• 1st edition I. P.
1955 was published in the official gazette. Dr. B. N. Ghosh, Chairman
– Supplement 1960
• 2nd edition I. P.
1966 Dr. B. Mukherji, Chairman
– Supplement 1975
• 3rd edition I. P.
1985 Dr. Nityanand, Chairman
– I Addendum/Supplement 1989
– II Addendum/Supplement 1991
• 4th edition I. P.
1996 Dr. Nityanand, Chairman
- Addendum/ Supplement 2000 for veterniary
- Addendum/ Supplement 2002
- Addendum/ Supplement 2005
• 5th edition I. P.
2007 Dr. Nityanand, Chairman
- Addendum/ Supplement 2008
• 6th edition I. P.
2010
- Addendum/ Supplement 2012
• 7th edition I. P.
2014 with DVD
- Addendum/ Supplement 2015
- Addendum/ Supplement 2016
• 8th edition I. P.
2018 with DVD
- Addendum/ Supplement 2019
- Addendum/ Supplement 2021
NATIONAL
FORMULARY OF INDIA:
_The authoritative guide to prescribing, dispensing and
administering medicines for all healthcare professionals.
-Information about drug interaction, resistance, cumulative
effects, drug dependence, prescription writing etc
The National Formulary of India editions:
• 1960 – The first edition of NFI National Formulary of
India
• 1966 – The Second edition of NFI National Formulary of
India
• 1979 – The Third edition of NFI National Formulary of
India
• 2011 – The Fourth edition of NFI National Formulary of
India
• 2016 – The Fifth Edition of NFI National Formulary of
India
• 2021 – The Sixth Edition of NFI National Formulary of
India
The British
Pharmacopoeia (B.P.)
• It was first published in 1864
• The new edition of British Pharmacopoeia is published at
intervals of five years i.e. 1948, 1953, 1958, 1963, 1968, 1973
• After 1973 the new edition was published in 1980 and then
in 1988,
1993, 1998, 2003, 2008
• After 2008 the new edition was published every year
• The addendums are also published from time to time in between
two main editions
• The BP contains monographs, which set out the mandatory
standards for active substances, excepients and formulated preparations,
together with General Notices, Appendices (test methods, reagents, etc ) and
Reference Spectra
British
Pharmaceutical Codex
• The Council of Pharmaceutical Society of Great Britain
decided to prepare a reference book for the use of medical practitioners and
dispensing pharmacists in 1903
• The first edition of British Pharmaceutical Codex was
published in 1907
• The subsequent revisions of this codex were published in
1911, 1923, 1934, 1949, 1954, 1959, 1963, 1968, and 1973
• The publication is still produced but since the Ninth
edition, it is now called the Pharmaceutical Codex: Principles and Practice of Pharmaceutics
• The 12th edition was published in 1994
• The latest edition is also available
United
State Pharmacopoeia- National Formulary
• An official public standards–setting authority for all
prescription and over–the–counter medicines and other health care products
manufactured or sold in the United States
• Standards for food ingredients and dietary supplements
• Originally published in 1820 under the authority of the
United States Pharmacopoeial Convention
• The National Formulary was published in 1888 under the
guidance of American Pharmaceutical Association
• In 1974 the National Formulary was purchased by the United
States Pharmacopoeial Convention and from 1980 onwards only one official book
of drug standards was published under the heading: The United States
Pharmacopoeia and The National Formulary (USP-NF)
• The USP–NF is a three volume combination of two official
compendia, the United States Pharmacopoeia (USP) and the National Formulary
(NF)
• Monographs for drug substances and preparations are
featured in the USP
• Monographs for dietary supplements and ingredients appear
in a separate section of the USP
• Excepients of monographs are in the NF
EXTRA
PHARMACOPOEIA (MARTINDALE)
• The Extra Pharmacopoeia was first produced in 1883 by
William Martindale and is still known as ‘Martindale’ Published by The Royal
Pharmaceutical Society of Great Britain
• The term “Extra” means in this instance “Outside”, because
the book aimed to describe drugs that were outside the British Pharmacopoeia.
THE MERCK
INDEX
• It is an encyclopedia of chemicals, drugs and biological
• The first edition was published in 1889 and the eleventh
edition was published in 1989 by Merck & Co., Inc. Rahway, New Jersy, USA
• The Merck Index is the definitive reference work for scientists
and professionals looking for authoritative information on chemicals, drugs and
biological
Indian
Pharmacopoeia Commission (IPC)
INDIAN PHARMACOPOEIA
MONOGRAPH DEVELOPMENT
Indian Pharmacopoeia
Commission (IPC):
• Formed in 1945 and
• 09th Dec. 2004: Autonomous institution of the Ministry of
Health and Family Welfare, Government of India.
Location of IPC
• The Office of the Commission is located at the Central
Indian Pharmacopoeia Laboratory Campus, Sector-23, Rajnagar, Ghaziabad-201 002,
India
• It is an ultra-modern premise having state-of-the art
infrastructure and excellent facilities
• www.ipc.gov.in
Mission:
• promote public health
• Standards for quality of drugs used by health
professionals, patients and consumers
Role of IPC
1. To publish new edition and supplements of the Indian
Pharmacopoeia
2. To accelerate the process of preparation, certification
and distribution of IP Reference Substances
3. To establish working relations with other Pharmacopeial
Bodies
Contents of
the Pharmacopoeia
The technical part of the pharmacopoeia shall be broadly
divided into the following sections:
• Introduction
• General Notices
• Monographs
• Test methods
• Reagents and Solutions
• General Texts
• Index
1. Introduction
• Written by IPC
• Background to the edition
• Salient features of the IP
• Deletions from previous edition
2. General Notices
• Basic guidelines to the interpretation
• Application of the standards, tests, assays and other
specifications of the pharmacopoeia
3. Formats and Contents of Monographs:
IP Monograph:
• All the parameters of quality set out in a monograph are
designed to determine the quality of a drug
Contents of Monographs: Include
• Active Pharmaceutical Ingredients (APIs) (Bulk Drug
Substances) Chemical Excipients
• Inactive Ingredients other than Chemicals Drugs of Plant
Origin
• Dosage Forms
• Vaccines, Immunosera and Products of Plant Origin
• General Monographs on Dosage Forms
A: Active
Pharmaceutical Ingredients (APIs) (Bulk Drug)
• Title of the Monograph: Sodium Aminosalicylate, Sodium PAS
• Formula: Nacl
• Chemical name: Ethionamide is
2-ethylpyridine-4-carbothioamide.
• Carbamazepine is 5H-dibenz(b,f)azepine-5-carboxamide
• Statement of purity: Ethionamide contains not less than
98.5 per cent and not more than 101.0 per cent of C8H10N2S, calculated on the
dried basis
• Description: A
white, crystalline powder or colourless, transparent crystals, efflorescent
• Identification: Instrumental, Physical, Chemical
• Appearance of solution: Method of preparing the test
solution to be given
• Other tests: pH, Specific optical rotation,
Light-absorbing impurities, Related substances, Arsenic, Heavy metals, Iron,
Chlorides, Sulphates, Non-volatile substances, Residual solvents, Microbial
contamination, Bacterial endotoxins, Sterility, Pyrogens, Water, Loss on drying
• Assay: Different types of titration
• Storage: Store protected from moisture
• Labeling: Depending upon the physical, chemical property
and dosage forms
B. Inactive
Ingredients other than Chemicals: Drugs of Plant Origin
• Title of the Monograph
• Description, Identification and other tests, including
Assay
• Relative density
• Weight per ml
• Refractive index
• Melting point
• Unsaponi-fiable matter
• Acetyl value, Hydroxyl value, Saponi-fication value,Iodine
value
• Acidity
• Freezing point
• Viscosity
• Peroxide value, Acid value, Ester
• Foreign matter, Total ash, Ash insoluble in hydrochloric
acid
• Storage
• Labelling
C. Dosage Forms
• Title of the Monograph
• Definition, Description
• Related substances
• Impurities
• Specific tests
• Disintegration Example Dissolution
• Assay
• Labelling
• Storage
D. Vaccines,
Immunosera and Products of Plant Origin
• The texts of the monographs
• Production
• Identification
• Tests
E. General Monographs
on Dosage Forms
The dosage forms for which General Monographs may be written
are as follows:
• Capsules
• Ear preparations
• Eye preparations
• Granules
• Liquids for oral use
• Nasal Preparations
• Parenteral preparations
• Oral powders
• Preparations for inhalation
• Creams and Ointments
• Rectal and vaginal preparations
• Tablets
The General Monographs shall be generally in three sections:
1. General description or definition of the dosage form and
its different types
2. Specific aspects of production that impact on the quality
of the product
3. Tests to be done in addition to the ones set out in the
individual monographs
4. Test Methods
Test Methods shall be broadly divided into the following
sections:
a. Apparatus
b. Physical and physicochemical methods
c. Identification tests
d. Limit tests
e. Chemical assays
f. Biological tests
g. Pharmaceutical tests
5. Reagents and Solutions
• Details of the quality and of preparation of reagents and
solutions that are to be used in the tests and assays of the pharmacopoeia
• Include information on Reference Substances that are
required for specific tests
6. General Texts
• General information, not specific to any product, but
pertaining to aspects of production
• Testing of pharmaceuticals impacting on quality such as
sterilisation, the quality of water for pharmaceutical use, containers
(including closures) for packing drugs and drug products etc
7. Index
The Index shall be in alphabetical order of:
• The titles of monographs
• Titles and sub-titles of test methods and of general
texts
• Reagents and special solutions mentioned in any of the
pages of the Pharmacopoeia except the cover page
Summary:
• Drug Compendia: Pharmacopoeia and Formularies-Standards of
drugs and other related substances
• Pharmacopoeia means “to make a drug”
• Before independence India followed British Pharmacopoeia.
• The first pharmacopoeia was published in1955
• Col. R. N. Chopra, called as father of pharmacology,
contributed pharmacopoeial list, first edition of IP and Pharmacy act
• I.P was first published in the year 1955, later on in the
following years 1966, 1985, 1996, 2007, 2010, 2014, 2018
• Revision and publication of new I.P is done by IPC
• Contents of pharmacopoeia: Inclusion of new monographs,
difference between previous and recent edition, salient features of I.P
• Monograph analysis of compound/ API: Name, synonym,
chemical formula, standard, description, solubility, test for purity, limit
tests, assay and storage
• Monograph analysis of plant origin, dosage forms, vaccines
and serum, general monograph procedure
• Preparing a known concentration of solutions and reagents
• General information like sterilization process, types of
containers to be used for packing
• Index arranged in alphabetical order for monographs,
reagents and solutions, various tests
0 Comments